-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES AMGEN’S UPLIZNA® (INEBILIZUMAB-CDON) FOR GENERALIZED MYASTHENIA GRAVIS (GMG), EXPANDING TREATMENT OPTIONS FOR PATIENTS LIVING WITH AUTOIMMUNE NEUROMUSCULAR DISEASE

路透·12/12/2025 17:43:59

登錄查看新聞詳情